DNA double-strand breaks (DSBs) are the most severe type of DNA damage, causing chromosomal translocations, genomic instability, and cell death. The researchers created the CDDR (CRISPR-Cas9-based Dual-fluorescent DSB Repair) assay to precisely detect and quantify DSB repair outcomes in mammalian cells. CDDR can discriminate between high-fidelity (HF), error-prone non-homologous end-joining (NHEJ), and homology-directed repair (HDR) by inserting one or two DSBs into an intrachromosomal fluorescent reporter with Cas9 and sgRNAs. CDDR demonstrated that HF-NHEJ is dependent on DNA Ligase IV, XRCC4, and XLF and that deleting these genes promotes HDR and error-prone end-joining. The deletion of the ATM kinase boosted HF-NHEJ and decreased HDR, demonstrating CDDR's value in researching DSB repair mechanisms.
Figure 1. Using the CDDR reporter assay, the researchers identify and assess DSB repair. Cas9-sgRNA-expressing plasmid transfections in U2OS-CDDR cells are followed by FACS analysis to determine Mut-NHEJ repair efficiency. (Eki R, et al., 2023)
Enhance your genome editing research with Creative Biogene's Cas9 Stable Cell Line-U2OS. Our stable cell line offers reliable and consistent Cas9 expression, ensuring efficient genome editing without the variability associated with transient transfection. By utilizing this advanced tool, researchers can streamline the generation of U2OS-CDDR cells with precise deletions in DNA repair genes, accelerating studies on DNA double-strand break repair mechanisms. Experience enhanced efficiency, reproducibility, and cost-effectiveness in your experiments with Creative Biogene's Cas9 Stable Cell Line-U2OS, your partner in cutting-edge genetic research.
The Cas9 Stable Cell Line-U2OS is an osteosarcoma cell line that has been genetically modified to express the Cas9 enzyme. This cell line is particularly useful for studying the genetic basis of bone diseases and for developing gene therapies.
(1)Bone Disease Research:
The U2OS Cas9 Stable Cell Line enables researchers to investigate the genetic factors that contribute to bone diseases such as osteoporosis and osteosarcoma. By using CRISPR-Cas9 to manipulate specific genes, scientists can explore their roles in bone formation, mineralization, and homeostasis.
(2)Gene Therapy Development:
The Cas9 expression in U2OS cells allows for the exploration of gene therapy strategies for bone disorders. Researchers can test the efficacy of gene-editing approaches to correct genetic defects or to modify genes that influence bone health, potentially leading to new therapeutic interventions.
(3)Cancer Biology and Treatment Resistance:
As an osteosarcoma cell line, U2OS is also used to study the biology of cancer and the mechanisms of treatment resistance. The Cas9 system can be employed to target genes that confer resistance to chemotherapy or radiation therapy, providing insights into how to overcome these challenges and improve cancer treatment outcomes.
Customer Q&As
How can the Cas9 Stable Cell Line-U2OS be used to investigate the role of specific genes in osteosarcoma development and progression?
A: The cell line can be utilized to perform CRISPR-Cas9-mediated gene editing to study the function of genes implicated in osteosarcoma. By knocking out or modifying these genes, researchers can determine their roles in tumor growth, survival, and metastasis, leading to potential therapeutic targets.
What insights can the Cas9 Stable Cell Line-U2OS provide into the mechanisms of osteosarcoma drug resistance?
A: By using CRISPR-Cas9 to target genes associated with drug resistance, the cell line can help researchers understand how these genes contribute to osteosarcoma cells' ability to evade chemotherapy and develop strategies to overcome resistance.
How can the Cas9 Stable Cell Line-U2OS be applied in the study of osteosarcoma genetics and potential gene therapy approaches?
A: The cell line can be used to model the genetic changes found in osteosarcoma and test the efficacy of gene therapy strategies, such as introducing corrected or therapeutic genes into the cells. This can provide valuable information on the feasibility and effectiveness of gene therapy for osteosarcoma.
What role does the Cas9 Stable Cell Line-U2OS play in understanding the molecular basis of osteosarcoma bone metastasis?
A: The cell line can be employed to study the genes and signaling pathways that contribute to the colonization of bones by osteosarcoma cells and the formation of bone metastases. This can lead to the identification of novel targets for preventing or treating bone metastasis in osteosarcoma patients.
How can the Cas9 Stable Cell Line-U2OS contribute to the development of targeted therapies for osteosarcoma based on genetic profiling?
A: By performing CRISPR-Cas9 screens and functional studies in the cell line, researchers can identify genetic vulnerabilities specific to osteosarcoma subtypes. This information can be used to develop targeted therapies that are tailored to the genetic profile of individual tumors, potentially improving treatment outcomes.
Ask a Question
Customer Reviews
High Precision Gene Editing
The Cas9 Stable Cell Line - U2OS enables precise genetic modifications due to the stable integration and constant expression of the Cas9 protein. This precision is essential for creating accurate disease models and investigating gene function, ensuring that changes in the genome are exact and reflect intended edits.
Efficient Research Workflows
Since Cas9 is already present and stably expressed, we using the Cas9 Stable Cell Line - U2OS can bypass the initial steps of introducing and establishing Cas9 expression systems. This efficiency streamlines the workflow, significantly reducing the time from experimental design to execution.
United Kingdom
06/12/2022
Reduced Background Activity
The controlled expression of Cas9 in the Cas9 Stable Cell Line - U2OS minimizes background genetic activity that could complicate results. This reduction is crucial for ensuring that experimental outcomes are due to the intended CRISPR edits and not to nonspecific Cas9 activity.
Facilitates Therapeutic Screening
With its robust genetic editing capability, the Cas9 Stable Cell Line - U2OS is an excellent tool for screening potential therapeutic interventions at the genetic level. We can test the effects of gene modulation on disease phenotypes, aiding in the development of gene-based therapies and understanding the genetic basis of disease.
United Kingdom
01/14/2023
Write a Review